• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在替代角色中发挥功能的困难是否等同于危重病研究中的脆弱性?运用路径分析来检验提供替代判断的困难与接受危重病研究参与之间的关系。

Does difficulty functioning in the surrogate role equate to vulnerability in critical illness research? Use of path analysis to examine the relationship between difficulty providing substituted judgment and receptivity to critical illness research participation.

作者信息

Clarridge Brian R, Bolcic-Jankovic Dragana, LeBlanc Jessica, Mahmood Rumel S, Kennedy Carie R, Freeman Bradley D

机构信息

Center for Survey Research, University of Massachusetts-Boston, Boston, MA.

Department of Surgery, Washington University School of Medicine, St Louis, MO.

出版信息

J Crit Care. 2015 Dec;30(6):1310-6. doi: 10.1016/j.jcrc.2015.07.016. Epub 2015 Jul 26.

DOI:10.1016/j.jcrc.2015.07.016
PMID:26304514
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4628890/
Abstract

PURPOSE

Individuals who struggle to provide substitute judgment for the critically ill often find it challenging to engage in decision making for therapeutic interventions. Although essential to the conduct of research, how these individuals respond to requests for clinical trial participation is poorly understood.

METHODS

Survey data collected to examine surrogate attitudes toward research provided the conceptual framework to explore influences on decision making. Path analysis was used to derive the final model (nonlatent, fully recursive, 1 indicator/variable).

RESULTS

Surrogates with list-wise complete records (406) were analyzed. The following variables were not retained in the final model: education, income, religiosity, decision-making experience, discussion of patient's wishes, number of individuals assisting with decision making, trust in care providers, difficulty making decisions, and responsibility for decision making. Being white and having experience making treatment decisions for the patient during the current intensive care unit encounter affected the likelihood the surrogate would permit participation in research positively (parameter estimates, 0.281 and 0.06, respectively). No variable reflecting difficulty functioning in the surrogate role was associated with permitting research participation.

CONCLUSIONS

We were unable to demonstrate a relationship between perceived difficulty in decision making in the surrogate role and receptivity to clinical trial participation.

摘要

目的

那些难以对重症患者做出替代判断的人,往往发现在进行治疗干预决策时颇具挑战性。尽管这对研究的开展至关重要,但这些人对参与临床试验请求的反应却鲜为人知。

方法

为检验替代者对研究的态度而收集的调查数据提供了探索决策影响因素的概念框架。采用路径分析得出最终模型(非潜在、完全递归、1个指标/变量)。

结果

对具有逐行完整记录的替代者(406人)进行了分析。以下变量未保留在最终模型中:教育程度、收入、宗教信仰、决策经验、对患者意愿的讨论、协助决策的人数、对医疗服务提供者的信任、决策难度以及决策责任。身为白人且在当前重症监护病房护理期间有为患者做出治疗决策的经验,会对替代者允许患者参与研究的可能性产生积极影响(参数估计分别为0.281和0.06)。没有任何反映替代者角色功能障碍的变量与允许参与研究相关。

结论

我们未能证明在替代者角色中感知到的决策困难与对参与临床试验的接受度之间存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e1/4628890/f6e58ab2a766/nihms-718041-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e1/4628890/43de86b1afc6/nihms-718041-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e1/4628890/f6e58ab2a766/nihms-718041-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e1/4628890/43de86b1afc6/nihms-718041-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e1/4628890/f6e58ab2a766/nihms-718041-f0002.jpg

相似文献

1
Does difficulty functioning in the surrogate role equate to vulnerability in critical illness research? Use of path analysis to examine the relationship between difficulty providing substituted judgment and receptivity to critical illness research participation.在替代角色中发挥功能的困难是否等同于危重病研究中的脆弱性?运用路径分析来检验提供替代判断的困难与接受危重病研究参与之间的关系。
J Crit Care. 2015 Dec;30(6):1310-6. doi: 10.1016/j.jcrc.2015.07.016. Epub 2015 Jul 26.
2
The Experience of Surrogate Decision Makers on Being Approached for Consent for Patient Participation in Research. A Multicenter Study.代理决策者在被征求患者参与研究同意时的经历。一项多中心研究。
Ann Am Thorac Soc. 2017 Feb;14(2):238-245. doi: 10.1513/AnnalsATS.201606-425OC.
3
Barriers and Facilitators of Surrogates Providing Consent for Critically Ill Patients in Clinical Trials: A Qualitative Study.代表重病患者参与临床试验时的同意书提供:定性研究中的障碍和促进因素。
Chest. 2024 Aug;166(2):304-310. doi: 10.1016/j.chest.2024.02.027. Epub 2024 Feb 20.
4
The Trial of Ascertaining Individual Preferences for Loved Ones' Role in End-of-Life Decisions (TAILORED) Study: A Randomized Controlled Trial to Improve Surrogate Decision Making.确定亲人在生命末期决策中角色偏好的试验(TAILORED):一项改善代理决策的随机对照试验。
J Pain Symptom Manage. 2017 Oct;54(4):455-465. doi: 10.1016/j.jpainsymman.2017.07.004. Epub 2017 Jul 14.
5
The Influence of Surrogate Decision Makers on Clinical Decision Making for Critically Ill Adults.替代决策者对危重症成年患者临床决策的影响
J Intensive Care Med. 2015 Jul;30(5):278-85. doi: 10.1177/0885066613516597. Epub 2013 Dec 20.
6
Developing the family support tool: An interactive, web-based tool to help families navigate the complexities of surrogate decision making in ICUs.开发家庭支持工具:一个互动的、基于网络的工具,帮助家庭在 ICU 中应对代理决策的复杂性。
J Crit Care. 2020 Apr;56:132-139. doi: 10.1016/j.jcrc.2019.12.002. Epub 2019 Dec 6.
7
Exploring determinants of surrogate decision-maker confidence: an example from the ICU.探究替代决策者信心的决定因素:以重症监护病房为例。
J Empir Res Hum Res Ethics. 2014 Oct;9(4):76-85. doi: 10.1177/1556264614545036. Epub 2014 Aug 7.
8
Advance care planning and end-of-life decision making in dialysis: a randomized controlled trial targeting patients and their surrogates.透析中的预先护理计划与临终决策:一项针对患者及其代理人的随机对照试验。
Am J Kidney Dis. 2015 Nov;66(5):813-22. doi: 10.1053/j.ajkd.2015.05.018. Epub 2015 Jun 30.
9
The effect of completing a surrogacy information and decision-making tool upon admission to an intensive care unit on length of stay and charges.完成一份代孕信息与决策工具对入住重症监护病房的住院时长及费用的影响。
J Clin Ethics. 2012 Summer;23(2):129-38.
10
Reconceptualizing the experience of surrogate decision making: reports vs genuine decisions.重新认识替代决策的体验:报告与真正的决策
Ann Fam Med. 2009 May-Jun;7(3):249-53. doi: 10.1370/afm.963.

本文引用的文献

1
Perspectives of Decisional Surrogates and Patients Regarding Critical Illness Genetic Research.决策代理人与患者对危重病基因研究的看法
AJOB Empir Bioeth. 2016 Jan 1;7(1):39-47. doi: 10.1080/23294515.2015.1039148. Epub 2015 May 1.
2
Exploring determinants of surrogate decision-maker confidence: an example from the ICU.探究替代决策者信心的决定因素:以重症监护病房为例。
J Empir Res Hum Res Ethics. 2014 Oct;9(4):76-85. doi: 10.1177/1556264614545036. Epub 2014 Aug 7.
3
Healthcare disparities in critical illness.危重病中的医疗保健差异。
Crit Care Med. 2013 Dec;41(12):2784-93. doi: 10.1097/CCM.0b013e3182a84a43.
4
Research recruitment practices and critically ill patients. A multicenter, cross-sectional study (the Consent Study).研究招募实践与重症患者。一项多中心、横断面研究(同意研究)。
Am J Respir Crit Care Med. 2013 Jun 1;187(11):1212-8. doi: 10.1164/rccm.201208-1537OC.
5
Identifying family members who may struggle in the role of surrogate decision maker.识别可能在代理决策角色中挣扎的家庭成员。
Crit Care Med. 2012 Aug;40(8):2281-6. doi: 10.1097/CCM.0b013e3182533317.
6
Real-time perspectives of surrogate decision-makers regarding critical illness research: findings of focus group participants.代决策者对危重病研究的实时观点:焦点小组参与者的发现。
Chest. 2012 Dec;142(6):1433-1439. doi: 10.1378/chest.11-3199.
7
Response rates and nonresponse errors in surveys.调查中的回应率和无回应误差。
JAMA. 2012 May 2;307(17):1805-6. doi: 10.1001/jama.2012.3532.
8
Considerations in the construction of an instrument to assess attitudes regarding critical illness gene variation research.关于构建一项用于评估对危重病基因变异研究态度的工具的考量因素。
J Empir Res Hum Res Ethics. 2012 Feb;7(1):58-70. doi: 10.1525/jer.2012.7.1.58.
9
A comparison of critical care research funding and the financial burden of critical illness in the United States.美国重症监护研究资金与重症疾病经济负担的比较。
Crit Care Med. 2012 Apr;40(4):1072-9. doi: 10.1097/CCM.0b013e31823c8d03.
10
Considering the vulnerabilities of surrogate decision-makers when obtaining consent for critical care research.考虑到在获取重症监护研究同意书时替代决策者的脆弱性。
Intensive Care Med. 2012 Jan;38(1):4-6. doi: 10.1007/s00134-011-2430-y. Epub 2011 Nov 26.